$5.45 Billion is the total value of Redmile Group, LLC's 81 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 29.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS INC | $325,830,000 | -13.4% | 23,075,807 | -7.5% | 5.98% | -13.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $275,066,000 | +122.4% | 3,234,934 | -7.3% | 5.05% | +121.2% |
| ARGX | Sell | ARGENX SEsponsored adr | $259,493,000 | +11.3% | 988,468 | -4.5% | 4.76% | +10.7% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $244,953,000 | -17.6% | 4,774,918 | -4.1% | 4.50% | -18.1% |
| ALLK | Sell | ALLAKOS INC | $197,562,000 | +5.0% | 2,425,560 | -7.4% | 3.63% | +4.4% |
| EPZM | Sell | EPIZYME INC | $99,158,000 | -27.2% | 8,311,633 | -2.1% | 1.82% | -27.7% |
| BNTX | Sell | BIONTECH SEsponsored ads | $85,544,000 | -58.2% | 1,235,645 | -59.7% | 1.57% | -58.5% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $81,917,000 | -12.8% | 3,327,262 | -0.9% | 1.50% | -13.3% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $76,823,000 | -30.6% | 3,391,757 | -0.6% | 1.41% | -31.0% |
| CI | Sell | CIGNA CORP NEW | $67,204,000 | -26.3% | 396,693 | -18.4% | 1.23% | -26.7% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $66,933,000 | -7.2% | 4,713,600 | -3.9% | 1.23% | -7.7% |
| NVRO | Sell | NEVRO CORP | $64,024,000 | +7.7% | 459,609 | -7.7% | 1.18% | +7.0% |
| RGNX | Sell | REGENXBIO INC | $61,319,000 | -25.6% | 2,228,166 | -0.4% | 1.13% | -26.0% |
| QURE | Sell | UNIQURE NV | $41,575,000 | -26.0% | 1,128,827 | -9.5% | 0.76% | -26.4% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $37,827,000 | -9.6% | 741,129 | -37.8% | 0.69% | -10.2% |
| IMGN | Sell | IMMUNOGEN INC | $37,720,000 | -31.7% | 10,477,879 | -12.7% | 0.69% | -32.2% |
| DXCM | Sell | DEXCOM INC | $34,385,000 | -12.8% | 83,412 | -14.3% | 0.63% | -13.3% |
| AMED | Sell | AMEDISYS INC | $33,143,000 | -26.2% | 140,180 | -38.0% | 0.61% | -26.7% |
| PPD | Sell | PPD INC | $31,556,000 | -39.1% | 853,092 | -55.9% | 0.58% | -39.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $29,500,000 | +13.5% | 1,989,200 | -0.5% | 0.54% | +12.9% |
| ICUI | Sell | ICU MED INC | $28,886,000 | -22.2% | 158,054 | -21.5% | 0.53% | -22.6% |
| CTLT | Sell | CATALENT INC | $28,218,000 | -6.8% | 329,419 | -20.3% | 0.52% | -7.3% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $28,194,000 | +3.7% | 277,936 | -0.5% | 0.52% | +3.2% |
| LMNX | Sell | LUMINEX CORP DEL | $23,995,000 | -19.6% | 914,107 | -0.4% | 0.44% | -20.0% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $23,557,000 | -16.8% | 466,205 | -21.5% | 0.43% | -17.4% |
| HOOK | Sell | HOOKIPA PHARMA INC | $17,452,000 | -19.3% | 1,842,902 | -1.0% | 0.32% | -19.8% |
| CABA | Sell | CABALETTA BIO INC | $15,031,000 | -5.4% | 1,386,584 | -2.8% | 0.28% | -5.8% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $11,010,000 | -75.5% | 2,548,620 | -49.7% | 0.20% | -75.6% |
| NVTA | Sell | INVITAE CORP | $8,453,000 | -35.3% | 195,003 | -54.8% | 0.16% | -35.7% |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $8,108,000 | -60.2% | 3,059,794 | -0.2% | 0.15% | -60.4% |
| IMVT | Sell | IMMUNOVANT INC | $4,256,000 | -70.9% | 120,940 | -79.8% | 0.08% | -71.1% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,389,000 | -67.9% | 163,619 | -60.6% | 0.03% | -67.5% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $338,000 | -98.7% | 25,162 | -96.0% | 0.01% | -98.8% |
| ELGXQ | Exit | ENDOLOGIX INC | $0 | – | -78,755 | -100.0% | -0.00% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -133,931 | -100.0% | -0.07% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -2,467,000 | -100.0% | -0.16% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -200,000 | -100.0% | -0.18% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -297,619 | -100.0% | -0.45% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -589,300 | -100.0% | -0.49% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -103,900 | -100.0% | -0.57% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -1,057,393 | -100.0% | -0.66% | – |
| NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -439,800 | -100.0% | -0.71% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -524,300 | -100.0% | -0.75% | – |
| CYRX | Exit | CRYOPORT INC | $0 | – | -1,817,663 | -100.0% | -1.02% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -585,000 | -100.0% | -1.19% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -4,705,308 | -100.0% | -2.89% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -2,712,388 | -100.0% | -2.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.